RxDoctor Payments Data

Manuel Fernandez, MD

Emergency Medicine · Pembroke Pines, FLNPI 1285684753

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AstraZeneca at 35.0% of the total. Among emergency medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,694in general payments, 2019–2025

Across 105 payments — averaging $35.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Novo Nordisk$590
  • Amarin Pharma, Inc.$547
  • Lilly USA, LLC$501
  • Exact Sciences$198
  • Bayer$117
  • plus $446 from 12 others
$11,727in research payments, 2019–2025

Across 7 payments — averaging $1675.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • National Marrow Donor Program$12K

What the payments were for

  • Food & beverage$3,694100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,694 in reported general payments places this provider in the 95th percentile of 3,289 emergency medicine providers in Florida.

See all emergency medicine providers in Florida

Medicare billing

Part B allowed, 2024
$36,439
Medicare patients
196
Services billed
253

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban19$15,887
Gabapentin12$717
Methylprednisolone53$363
Cefdinir15$214
Ibuprofen40$157
Tizanidine Hcl40$155
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$122
Pantoprazole Sodium13$94
Naproxen34$92
Tramadol Hcl35$83
Metoprolol Succinate12$80
Atorvastatin Calcium22$72
Metformin Hcl21$65
Lisinopril19$64
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen14$49

Paid to pharmacies, not to this prescriber.

Other emergency medicine in Pembroke Pines

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →